Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Gavvovidis, Ioannis Dr. (1) Kammertöns, Thomas Dr. (3) Kettenmann, Helmut Prof. Dr. (2) Leisegang, Matthias Dr. (6) Lorenz, Felix Dr. (3) Poncette, Lucia (1) Rhein, Simone Dr. (2) Uckert, Wolfgang Prof. Dr. (24) (-) Blankenstein, Thomas Prof. Dr. (10) (-) Obenaus, Matthias (1) Bioinformatics (1) Biologie maligner Lymphome (20) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Immunologie und Gentherapie (32) (-) Molekulare Zellbiologie und Gentherapie (10) Proteom Dynamik (2) RNA Biologie und Posttranscriptionale Regulation (1) Signaltransduktion in Tumorzellen (3) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (4) Translationale Onkologie solider Tumore (1) Zelldifferenzierung und Tumorigenese (2) Zellzustände und ihre Funktionsweisen (1) 1998 (2) 2000 (2) 2003 (4) 2004 (1) (-) 2005 (3) 2006 (2) 2007 (1) (-) 2008 (1) 2010 (1) (-) 2011 (2) (-) 2014 (1) (-) 2015 (2) 2016 (1) 2017 (1) 2018 (1) (-) 2019 (1) 10 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Obenaus, MatthiasMolekulare Zellbiologie und Gentherapie200520082011201420152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 01. September 2014 in Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski 28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 15. Januar 2008 in Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 01. Juli 2005 in Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert 20. Mai 2005 in Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein 01. Januar 2005 in Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. September 2014 in Eur J Immunol Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells S. Pinto D. Sommermeyer C. Michel S. Wilde D. Schendel W. Uckert T. Blankenstein B. Kyewski
28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
15. Januar 2008 in Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
01. Juli 2005 in Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert
20. Mai 2005 in Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
01. Januar 2005 in Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
